Allergan Doesn’t Oppose MDL For Biocell Breast Implants But Suggests New Jersey

(November 4, 2019, 1:45 PM EST) -- WASHINGTON, D.C. — Allergan Inc. on Nov. 1 told a federal judicial panel that it does not opposed centralization of 17 federal medical monitoring lawsuits involving Biocell textured breast implants but...
To view the full article, register now.